Replies to post #248338 on NorthWest Biotherapeutics Inc (NWBO)

[Smokey21]

Looks like another cash infusion of a couple of million, with a dilution of around 10 million shares. Total issued shares and options including this dilution would be around 1,055,000 if all warrants/options are exercised (which would generate another $125 Million in cash to the company. I like that this offering is discounted to market, but no warrants are included. Sounds like it is going to friendlies.

[sentiment_stocks]

Well, it depends on what you consider as the "end".

What I see is completion of the SAP and unblinding, but top line not being given straight away. The reason for this is that the unblinded data would need to be reviewed by the stat people, Scientific Advisory Board and Steering committee; and from there, the pathway(s) forward with the various regulators determined. I think at this time, they would announce top line, as well as their intended pathways, and their intents to file their applications.

So, yes, I see the end of waiting for top line as near. I see the beginning of a new (and much better) era in front of this company. I think that will be of benefit to those who have waited this long, and I think it will represent a far better alternative to solid tumor cancer patients.